OrganoClick AB (publ) (STO:ORGC)
Sweden · Delayed Price · Currency is SEK 0.3860
-0.0130 (-3.26%)
Aug 14, 2026, 5:20 PM CET
OrganoClick AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 90.28 | 106.19 | 127.23 | 145.87 | 115.05 | 110.06 | |
Revenue Growth | -21.95% | -16.54% | -12.78% | 26.79% | 4.53% | 14.11% |
Cost of Revenue | 70.27 | 85.43 | 95.39 | 110.48 | 91.56 | 91.55 |
Gross Profit | 20.01 | 20.76 | 31.84 | 35.39 | 23.49 | 18.51 |
Selling, General & Admin | 34.07 | 40.04 | 36.88 | 37.23 | 42.86 | 39.94 |
Research & Development | 7.05 | 6.33 | 5.93 | 6.65 | 8.13 | 7.5 |
Other Operating Expenses | -0.49 | -0.47 | -0.43 | 3.26 | -1.18 | -1.03 |
Operating Expenses | 40.63 | 45.9 | 42.38 | 47.14 | 49.81 | 46.41 |
Operating Income | -20.62 | -25.14 | -10.55 | -11.75 | -26.33 | -27.9 |
Interest Expense | -7.18 | -6.74 | -6.17 | -4.96 | -3.23 | -2.65 |
Interest & Investment Income | - | 0.02 | 0.04 | 0.1 | 0.02 | 0.07 |
Currency Exchange Gain (Loss) | 0.1 | -0.41 | 0.46 | -0.2 | 0.01 | -0.22 |
Other Non Operating Income (Expenses) | 0.01 | 0 | -0 | -0 | - | - |
EBT Excluding Unusual Items | -27.69 | -32.28 | -16.22 | -16.81 | -29.53 | -30.7 |
Merger & Restructuring Charges | -5.9 | -5.9 | - | - | -5.3 | - |
Gain (Loss) on Sale of Assets | -0.12 | -0.12 | 0.22 | -0.02 | 2.44 | -0.47 |
Asset Writedown | - | - | - | - | -9.33 | - |
Pretax Income | -33.7 | -38.29 | -16 | -14.09 | -41.72 | -31.17 |
Income Tax Expense | 0.07 | -0.29 | 0.18 | 0.07 | -0.1 | -0.14 |
Earnings From Continuing Operations | -33.77 | -38 | -16.18 | -14.16 | -41.62 | -31.03 |
Minority Interest in Earnings | 1.59 | 1.63 | -1.79 | -1.62 | -2.78 | -1.65 |
Net Income | -32.19 | -36.37 | -17.97 | -15.77 | -44.4 | -32.69 |
Net Income to Common | -32.19 | -36.37 | -17.97 | -15.77 | -44.4 | -32.69 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 108 | 102 | 98 | 98 | 98 | 96 |
Shares Outstanding (Diluted) | 108 | 102 | 98 | 98 | 98 | 96 |
Shares Change | 9.90% | 3.92% | 0.10% | - | 2.17% | 3.66% |
EPS (Basic) | -0.30 | -0.36 | -0.18 | -0.16 | -0.45 | -0.34 |
EPS (Diluted) | -0.30 | -0.36 | -0.18 | -0.16 | -0.45 | -0.34 |
EPS Growth | - | - | - | - | - | - |
Free Cash Flow | -5.45 | -10.51 | 1.67 | -1.23 | -29.15 | -45.16 |
Free Cash Flow Per Share | -0.05 | -0.10 | 0.02 | -0.01 | -0.30 | -0.47 |
Gross Margin | 22.16% | 19.55% | 25.02% | 24.26% | 20.41% | 16.82% |
Operating Margin | -22.84% | -23.67% | -8.29% | -8.06% | -22.88% | -25.35% |
Profit Margin | -35.66% | -34.25% | -14.12% | -10.81% | -38.59% | -29.70% |
Free Cash Flow Margin | -6.03% | -9.90% | 1.31% | -0.84% | -25.34% | -41.03% |
EBITDA | -15.61 | -19.2 | -5.18 | -6.99 | -19.41 | -21.68 |
EBITDA Margin | -17.29% | -18.08% | -4.07% | -4.79% | -16.87% | -19.70% |
D&A For EBITDA | 5.01 | 5.94 | 5.37 | 4.76 | 6.92 | 6.22 |
EBIT | -20.62 | -25.14 | -10.55 | -11.75 | -26.33 | -27.9 |
EBIT Margin | -22.84% | -23.67% | -8.29% | -8.06% | -22.88% | -25.35% |